Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction

References

• Baschat, AA Fetal Growth Restriction: From Observation to Intervention, J Perinat Med. 2010:38:239–246.
   PubMed Web of Science ®Google Scholar
• Figueras, F, Gratacós, E. Update on the Diagnosis and Classification of Fetal Growth Restriction and Proposal of a Stage-based Management Protocol, Fetal Diagn Ther. 2014:36:86–98.
   PubMed Web of Science ®Google Scholar
• Minakami, H, Maeda, T, Fujii, T, et al. Guidelines for Obstetrical Practice in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2014 edition, J Obstet Gynaecol Res. 2014:40:1469–1499.
   PubMed Web of Science ®Google Scholar
• Hagmann, H, Thadhani, R, Benzing, T, et al. The Promise of Angiogenic Markers for the Early Diagnosis and Prediction of Preeclampsia, Clin Chem. 2012:58:837–845.
   PubMed Web of Science ®Google Scholar
• Baschat, AA. Neurodevelopment Following Fetal Growth Restriction and its Relationship with Antepartum Parameters of Placental Dysfunction, Ultrasound Obstet Gynecol. 2011:37:501–514.
   PubMed Web of Science ®Google Scholar
• Luttun, A, Carmeliet, P. Soluble. VEGF Receptor Flt1: The Elusive Preeclampsia Factor Discovered? J Clin Invest. 2003:111:600–602.
   PubMed Web of Science ®Google Scholar
• Korzeniewski, SJ, Romero, R, Chaiworapongsa, T, et al. Maternal Plasma Angiogenic Index-1 (Placental Growth Factor/Soluble Vascular Endothelial Growth Factor Receptor-1) is a Biomarker for the Burden of Placental Lesions Consistent with Uteroplacental Underperfusion: A Longitudinal Case-cohort Study, Am J Obstet Gynecol. 2016:214:629.e1-629.e17.
   Web of Science ®Google Scholar
• Rana, S, Powe, CE, Salahuddin, S, et al. Angiogenic Factors and the Risk of Adverse Outcomes in Women with Suspected Preeclampsia, Circulation. 2012:125:911–919.
   PubMed Web of Science ®Google Scholar
• Levine, RJ, Maynard, SE, Qian, C, et al. Circulating Angiogenic Factors And the Risk of Preeclampsia, N Engl J Med. 2004:350:672–683.
   PubMed Web of Science ®Google Scholar
• Verlohren, S, Stepan, H, Dechend, R. Angiogenic Growth Factors in the Diagnosis and Prediction of Pre-eclampsia, Clin Sci (London). 2012:122:43–52.
   PubMed Web of Science ®Google Scholar
• Wallner, W, Sengenberger, R, Strick, R, et al. Angiogenic Growth Factors in Maternal and Fetal Serum in Pregnancies Complicated by Intrauterine Growth Restriction, Clin Sci. 2007:112:51–57.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa, T, Romero, R, Whitten, AE, et al. The Use of Angiogenic Biomarkers In Maternal Blood to Identify which SGA Fetuses will Require a Preterm Delivery and Mothers Who Will Develop Pre-eclampsia, J Matern Fetal Neonatal Med. 2015:14:1–15.
   Google Scholar
• Lobmaier, SM, Figueras, F, Mercade, I, et al. Angiogenic Factors vs Doppler Surveillance in the Prediction of Adverse Outcome among Late-pregnancy Small-for- gestational-age Fetuses, Ultrasound Obstet Gynecol. 2014:43:533–540.
   PubMed Web of Science ®Google Scholar
• Shinozuka, N, Akamatsu, N, Sato, S, et al. Ellipse Tracing fetal Growth Assessment using Abdominal Circumference: JSUM Standardization Committee for Fetal Measurements, Journal of Medical Ultrasound. 2000:8:87–94.
   Google Scholar
• Watanabe, K, Naruse, N, Tanaka, K, et al. Outline of Definition and Classification of “Pregnancy induced Hypertension (PIH),” Hyperten Res Pregnancy. 2013:1:3–4.
   Google Scholar
• Shinozuka, N Fetal. biometry and Fetal Weight Estimation: JSUM Standardization, Ultrasound Rev Obst Gynecol. 2002:2:156–161.
   Google Scholar
• Ebrashy, A, Azmy, O, Ibrahim, M, et al. Middle Cerebral/Umbilical Artery Resistance Index Ratio as Sensitive Parameter for Fetal Well-being and Neonatal Outcome in Patients with Preeclampsia: Case-control Study, Croat Med J. 2005:46:821–825.
   PubMed Web of Science ®Google Scholar
• Hasegawa, Y, Aoki, S, Kurasawa, K, et al. Association of Biparietal Diameter Growth Rate with Neurodevelopment in Infants with Fetal Growth Restriction, Taiwan J Obstet Gynecol. 2015:54:371–375.
   PubMed Web of Science ®Google Scholar
• Jiang, Z, Zou, Y, Ge, Z, et al. A role of sFlt-1 in Oxidative Stress and Apoptosis in Human and Mouse Pre-eclamptic Trophoblasts, Biol Reprod. 2015:93:73.
   PubMed Web of Science ®Google Scholar
• Marchetti, C, De Felice, F, Palaia I, et al. Efficacy and Toxicity of Bevacizumab in Recurrent Ovarian Disease: An Update Meta-analysis On Phase III trials, Oncotarget. 2016:7:13221–13227.
   PubMed Web of Science ®Google Scholar
• Hassan, MF, Rund, NM, Salama AH. An Elevated Maternal Plasma Soluble Fms-like Tyrosine Kinase-1 to Placental Growth Factor Ratio At Midtrimester is a Useful Predictor for Preeclampsia, Obstet Gynecol Int. 2013:2013:202346.
   PubMedGoogle Scholar
• Chappell, LC, Duckworth, S, Seed, PT, et al. Diagnostic Accuracy of Placental Growth Factor in Women with Suspected Preeclampsia: A Prospective Multicenter Study, Circulation. 2013:128:2121–2131.
   PubMed Web of Science ®Google Scholar
• Amorim, MM, Santos, LC, Faúndes, A. Corticosteroid Therapy for Prevention of Respiratory Distress Syndrome in Severe Preeclampsia, Am J Obstet Gynecol. 1999:180:1283–1288.
   PubMed Web of Science ®Google Scholar
• Stimac, T, Petrović, O, Krajina, R, et al. The Influence of Pre-eclampsia on Fetal Lung Maturity, Int J Gynaecol Obstet. 2012:118:18–20.
   PubMed Web of Science ®Google Scholar
• Zeisler, H, Llurba, E, Chantraine, F, et al. Predictive Value of the sFlt-1: PLGF ratio in Women with suspected preeclampsia, N Engl J Med. 2016:374:13–22.
   PubMed Web of Science ®Google Scholar
• Predanic, M, Cho, A, Ingrid, F, et al. Ultrasonographic Estimation of Fetal Weight: Acquiring Accuracy in Residency, J Ultrasound Med. 2002:21:495–500.
   PubMed Web of Science ®Google Scholar